glp-1 agonist cost The Rising Tide of Costs: Can Your Health Plan Stay Afloat? GLP-1 Agonists Market Report 2025-2033,
Description
Retrieved from Muller, D
10.1056/NEJMoa2413258 89 SawadaN.AdachiK.NakamuraN.MiyabeM.ItoM.KobayashiS.et al (2020)
Head-to-head trials against semaglutide are recruiting and have not been reported
Finally, summarizing the data on metabolic outcomes is challenging because of significant variability in effects
